Half-year report · HY

Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥1.22T2026-01-01 → 2026-06-30Cons.Revenue IFRS
Revenue¥2.43T2025-01-01 → 2025-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.14T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Operating income¥129.0bn2026-01-01 → 2026-06-30Cons.Operating profit loss IFRS
Operating income¥68.7bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Profit before tax¥150.9bn2026-01-01 → 2026-06-30Cons.Profit loss before tax IFRS
Profit before tax¥237.9bn2025-01-01 → 2025-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥83.8bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥101.7bn2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥147.5bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥52.8bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥116.1bn2026-01-01 → 2026-06-30Cons.Profit loss IFRS
Net income¥60.5bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Total assets¥3.40Tat 2026-06-30Cons.Assets IFRS
Total assets¥3.49Tat 2025-12-31Cons.Assets IFRS
Total assets¥3.30Tat 2025-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.72Tat 2026-06-30Cons.Liabilities IFRS
Total liabilities¥1.90Tat 2025-12-31Cons.Liabilities IFRS
Net assets / equity¥1.68Tat 2026-06-30Cons.Equity IFRS
Net assets / equity¥1.60Tat 2025-12-31Cons.Equity IFRS
Net assets / equity¥1.41Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥1.53Tat 2024-12-31vCons.Equity IFRS
Equity (owners)¥1.36Tat 2026-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.29Tat 2025-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.12Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥168.1bnat 2026-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥125.3bnat 2025-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥132.4bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥118.6bnat 2024-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥137.3bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥295.4bn2025-01-01 → 2025-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥67.3bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥53.7bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥185.0bn2025-01-01 → 2025-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥61.6bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥162.5bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥110.5bn2025-01-01 → 2025-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥35.8bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥126.332026-01-01 → 2026-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥182.132025-01-01 → 2025-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥65.232025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥182.132025-01-01 → 2025-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥65.222025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio40.0%at 2026-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio36.8%at 2025-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio34.0%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2026-01-01 → 2026-06-30¥46.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2026-01-01 → 2026-06-30¥12.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2026-01-01 → 2026-06-30¥33.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2026-01-01 → 2026-06-30−¥1.5bn
Reconciling Itemsreconcilingrevenue2026-01-01 → 2026-06-30−¥38.9bn
Reconciling Itemsreconcilingrevenue intersegment2026-01-01 → 2026-06-30−¥38.9bn
Reconciling Itemsreconcilingsegment profit2026-01-01 → 2026-06-30−¥34.2bn
Alcoholic Beveragesreportable segmentrevenue2026-01-01 → 2026-06-30¥519.1bn
Alcoholic Beveragesreportable segmentrevenue external2026-01-01 → 2026-06-30¥517.8bn
Alcoholic Beveragesreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥1.3bn
Alcoholic Beveragesreportable segmentsegment profit2026-01-01 → 2026-06-30¥62.1bn
Health Sciencereportable segmentrevenue2026-01-01 → 2026-06-30¥131.1bn
Health Sciencereportable segmentrevenue external2026-01-01 → 2026-06-30¥128.8bn
Health Sciencereportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥2.3bn
Health Sciencereportable segmentsegment profit2026-01-01 → 2026-06-30¥10.4bn
Non Alcoholic Beveragesreportable segmentrevenue2026-01-01 → 2026-06-30¥296.7bn
Non Alcoholic Beveragesreportable segmentrevenue external2026-01-01 → 2026-06-30¥294.9bn
Non Alcoholic Beveragesreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥1.8bn
Non Alcoholic Beveragesreportable segmentsegment profit2026-01-01 → 2026-06-30¥31.0bn
Pharmaceuticalsreportable segmentrevenue2026-01-01 → 2026-06-30¥263.6bn
Pharmaceuticalsreportable segmentrevenue external2026-01-01 → 2026-06-30¥263.5bn
Pharmaceuticalsreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥139m
Pharmaceuticalsreportable segmentsegment profit2026-01-01 → 2026-06-30¥60.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥47.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥14.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥32.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥591m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥30.0bn
Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥493.8bn
Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥492.6bn
Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.2bn
Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥53.2bn
Health Sciencereportable segmentrevenue2025-01-01 → 2025-06-30¥129.7bn
Health Sciencereportable segmentrevenue external2025-01-01 → 2025-06-30¥127.2bn
Health Sciencereportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥2.5bn
Health Sciencereportable segmentsegment profit2025-01-01 → 2025-06-30¥8.6bn
Non Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥273.4bn
Non Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥271.8bn
Non Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.6bn
Non Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥29.5bn
Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥230.7bn
Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥230.5bn
Pharmaceuticalsreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥156m
Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥33.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 869
ItemContextValueUnit
Comprehensive income IFRSPrior1InterimDuration2282000000JPY
Dividends ss IFRSPrior1InterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Dividends ss IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Dividends ss IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember-JPY
Dividends ss IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember-28755000000JPY
Dividends ss IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember-6997000000JPY
Dividends ss IFRSPrior1InterimDuration-35752000000JPY
Purchase of treasury shares ss IFRSPrior1InterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Purchase of treasury shares ss IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Purchase of treasury shares ss IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember-JPY
Purchase of treasury shares ss IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember-9000000JPY
Purchase of treasury shares ss IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember-JPY
Purchase of treasury shares ss IFRSPrior1InterimDuration-9000000JPY
Disposal of treasury shares ss IFRSPrior1InterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Disposal of treasury shares ss IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Disposal of treasury shares ss IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember-JPY
Disposal of treasury shares ss IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember8000000JPY
Disposal of treasury shares ss IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember-JPY
Disposal of treasury shares ss IFRSPrior1InterimDuration8000000JPY
Share based payment transactions ss IFRSPrior1InterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Share based payment transactions ss IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Share based payment transactions ss IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember-JPY
Share based payment transactions ss IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember254000000JPY
Share based payment transactions ss IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember-27000000JPY
Share based payment transactions ss IFRSPrior1InterimDuration227000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1InterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember-JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember-19872000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember-62612000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1InterimDuration-82484000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember14000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1InterimDuration-JPY
Transfer from retained earnings to share premium ss IFRSPrior1InterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSPrior1InterimDuration-JPY
Total transactions with owners IFRSPrior1InterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Total transactions with owners IFRSPrior1InterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Total transactions with owners IFRSPrior1InterimDuration_OtherComponentsOfEquityIFRSMember14000000JPY
Total transactions with owners IFRSPrior1InterimDuration_EquityAttributableToOwnersOfParentIFRSMember-48374000000JPY
Total transactions with owners IFRSPrior1InterimDuration_NonControllingInterestsIFRSMember-69636000000JPY
Total transactions with owners IFRSPrior1InterimDuration-118011000000JPY
Equity IFRSPrior1InterimInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember115519000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-12-31pass rounding
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass